SII

Latest News

SII Seeks Govt’s Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical Cancer

The SII will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI) for the vaccine.

The application mentions that every year, lakhs of women are diagnosed with cervical cancer and the death ratio is also very high. In India, cervical cancer ranks as the second most frequent cancer among women in the 15-44 age group.

View Post

UP Man Alleges No Antibodies Developed Post Vaccine, Files Complaint Against SII CEO, ICMR Chief

A man from Lucknow, Uttar Pradesh has lodged a complaint against the Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava the head of the Indian Council…

View Post

Serum Institute of India (SII) Has Not Contracted All Its Production Of COVID Vaccine To The Centre Till 25th May 2021

There have been some media reports suggesting that Serum Institute of India (SII) has contracted all its production till 25th May 2021 to the Centre, and therefore till that date…

View Post

Mutant Covid-19 Strain May Force Serum Institute To Alter Vaccine Composition

After the World Health Organization’s (WHO) Strategic Advisory Group of Experts on Immunization (SAGE) expressed concerns about the effectiveness of the vaccine against the South African mutant coronavirus strain, the…

View Post

Spotlight

How Much Will Serum’s Covishield, And Bharat Biotech’s Covaxin Cost?

As the country prepares for the Mega Covid-19 vaccination drive scheduled to start on 16 January, the Ministry of Health of the Union gave a thorough explanation on the Indian…

View Post

First Flight With Covid-19 Vaccines Reaches Delhi

The first batches of Covishield, the vaccine developed by the Serum Institute of India (SII), left Pune to be taken to different parts of the country ahead of the coronavirus…

View Post

Latest News

Covid-19 Vaccine: SII Stockpiles 40-50 Million Doses, To Produce 300 Million Shots By July

The Pune-based vaccine maker, Serum Institute of India (SII) is ready with a stockpile of 40 to 50 million doses of ‘Covishield‘, the COVID-19 vaccine developed by Oxford University and…

View Post

Menu

SII Seeks Govt’s Nod To Manufacture, Stockpile qHPV Vaccine Against Cervical Cancer

UP Man Alleges No Antibodies Developed Post Vaccine, Files Complaint Against SII CEO, ICMR Chief

Serum Institute of India (SII) Has Not Contracted All Its Production Of COVID Vaccine To The Centre Till 25th May 2021

Mutant Covid-19 Strain May Force Serum Institute To Alter Vaccine Composition

How Much Will Serum’s Covishield, And Bharat Biotech’s Covaxin Cost?

First Flight With Covid-19 Vaccines Reaches Delhi

Covid-19 Vaccine: SII Stockpiles 40-50 Million Doses, To Produce 300 Million Shots By July

Methanol Poisoning: All You Need to Know About The Silent Killer Lurking in Alcoholic Drinks

Winter Heart Attack Alert: 8 Doctor-Approved Lifestyle Changes for Better Cardiovascular Health

Sea Level Set to Rise 1 Metre by 2100, Threatening 14 Million in Coastal Regions: Study Warns

Not Just Smog, Surge in ‘Walking Pneumonia’ Cases Alarms Delhi Residents

Man Declared Dead In Rajasthan Hospital Found Alive Before Last Rites; 4 Doctors Suspended

Breathlessness and Persistent Coughing: Early Signs of a Progressive Lung Disease, Experts Warn

Walking Pneumonia Symptoms: The Silent Respiratory Illness You Could Be Overlooking

Diabetes Treatment Breakthrough: Canagliflozin Improves Kidney Oxygenation, Shows Study